Publications by authors named "Piotr Hantulik"
The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice.
J Asthma
April 2023
Article Synopsis
- A study evaluated the effectiveness and safety of the Salflumix Easyhaler, a dry powder inhaler for asthma treatment, involving 2,037 adult patients across Poland.
- Results showed a significant increase in asthma control from 35.5% to 86.5% over three visits, indicating strong clinical effectiveness.
- Patient satisfaction with the device was high, adherence rates were above 95%, and the overall feedback from physicians about the Salflumix Easyhaler was notably positive.
Introduction: The effectiveness of single-inhaler budesonide/formoterol fumarate combination therapy for asthma has been previously shown for the original product. The aim of this nonrandomized, open-label, postauthorization efficacy study (PAES) real-life clinical assessment was to evaluate the clinical effectiveness of a second product (Bufomix Easyhaler) in the daily clinical practice of asthma therapy.
Methods: This multicenter PAES was conducted by 220 unselected allergologists and pulmonologists who enrolled 2200 adult outpatients (age 49.
Introduction: Inhalation is the preferred route of drug administration for patients with asthma or COPD. It is generally predicted that there is a high error rate in inhaler usage, especially at the therapy start. The primary objective of this study was the validation of a questionnaire that can be used for assessing a successful inhalation technique, patient satisfaction as well as the compliance in daily practice.
View Article and Find Full Text PDF